Access cutting-edge langerhans cell histiocytosis treatment through this clinical trial at a research site in Madera. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Madera location
Preparing your pre-screening questions…
Access langerhans cell histiocytosis specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related langerhans cell histiocytosis treatment provided free
Check if you qualify for this langerhans cell histiocytosis clinical trial in Madera, CA
No-Cost Study Care
Local to Madera
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This phase II trial tests the safety, side effects, best dose and activity of tovorafenib (DAY101) in treating patients with Langerhans cell histiocytosis that is growing, spreading, or getting worse (progressive), has come back (relapsed) after previous treatment, or does not respond to therapy (refractory). Langerhans cell histiocytosis is a type of disease that occurs when the body makes too many immature Langerhans cells (a type of white blood cell). When these cells build up, they can form
Sponsor: National Cancer Institute (NCI)
Yes, this clinical trial (NCT05828069) has an active research site in Madera, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for langerhans cell histiocytosis treatment options in Madera, CA, this clinical trial (NCT05828069) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Madera research site is actively enrolling participants for this clinical trial. You'll receive care from experienced langerhans cell histiocytosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.